Yara Abdou, Assistant Professor at University of North Carolina at Chapel Hill, shared a post by American Society of Clinical Oncology (ASCO) on X, adding:
“Incredibly grateful to Conquer Cancer, the ASCO Foundation, The Breast Cancer Research Foundation, Gateway for Cancer Research, Translational Breast Cancer Research Consortium for all their support of PREDICT-RD/TBCRC-071 and this important work in MRD and early-stage TNBC.
BIG thanks to ASCO for highlighting!”
Quoting ASCO’s post:
“Take an escalator ride with Yara Abdou as she gives a quick snapshot of her ASCO26 abstract. Her research, funded by Conquer Cancer, the ASCO Foundation
Career Development Award, evaluates clinical implications of post-surg ctDNA monitoring in patients with high-risk early-stage TNBC.”
Title: PREDICT-RD: Postoperative molecular residual disease by ctDNA
surveillance in TNBC with residual disease (TBCRC-071)
Authors: Yara Abdou, Naim Rashid, Katherine E. Reeder-Hayes, Allison Camp, Patty Spears, Lynne I. Wagner, Philip Miller, Ekaterina Kalashnikova, Jamie E. McKenzie, Minetta C. Liu, Angel A. Rodriguez, Lisa A. Carey, Gaorav P. Gupta
Read the Full Abstract.
Other articles about Yara Abdou on OncoDaily.